Detalhe da pesquisa
1.
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 25(5): 603-613, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588682
2.
Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study.
Breast Cancer Res Treat
; 204(2): 277-288, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133707
3.
Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement.
Br J Surg
; 111(3)2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531689
4.
Clinical impact of MRI-detected additional lesions in breast cancer patients with neoadjuvant systemic therapy at the Netherlands cancer institute.
Breast Cancer Res Treat
; 198(1): 131-141, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592232
5.
Immediate or delayed oncoplastic surgery after breast conserving surgery at the Netherlands Cancer Institute: a cohort study of 251 cases.
Breast Cancer Res Treat
; 198(2): 295-307, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690822
6.
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study.
Breast Cancer Res Treat
; 199(1): 81-89, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892723
7.
Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study.
Breast Cancer Res Treat
; 197(1): 161-175, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334188
8.
Management of Benign Phyllodes Tumors: A Dutch Population-Based Retrospective Cohort Between 1989 and 2022.
Ann Surg Oncol
; 30(13): 8344-8352, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639031
9.
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol.
Breast Cancer Res Treat
; 193(1): 37-48, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239072
10.
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer.
Breast Cancer Res Treat
; 189(1): 213-224, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945043
11.
Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience.
Ann Surg Oncol
; 28(12): 7383-7394, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978889
12.
Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.
Ann Surg Oncol
; 28(6): 3243-3253, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33263830
13.
Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer.
Int J Cancer
; 147(1): 152-159, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721193
14.
Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI?
Breast Cancer Res Treat
; 184(2): 385-395, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32770456
15.
From Multiple Quality Indicators of Breast Cancer Care Toward Hospital Variation of a Summary Measure.
Value Health
; 23(9): 1200-1209, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940238
16.
Effect of Case-Mix and Random Variation on Breast Cancer Care Quality Indicators and Their Rankability.
Value Health
; 23(9): 1191-1199, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940237
17.
Internal Mammary Chain Sentinel Nodes in Early-Stage Breast Cancer Patients: Toward Selective Removal.
Ann Surg Oncol
; 26(4): 945-953, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30465222
18.
Feasibility of Micro-Computed Tomography Imaging for Direct Assessment of Surgical Resection Margins During Breast-Conserving Surgery.
J Surg Res
; 241: 160-169, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31026794
19.
ASO Author Reflections: Biopsy Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial.
Ann Surg Oncol
; 30(8): 4690-4692, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202571
20.
ASO Visual Abstract: Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient-Additional Pathology Findings of the MICRA Trial.
Ann Surg Oncol
; 30(8): 4693-4694, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37160807